胸肌前乳房重建术后预防性抗生素的应用:单术者经验
该单术者回顾性研究纳入2015至2018年乳房切除后立即行胸肌前组织扩张器置入的患者,比较出院时接受与未接受预防性抗生素两组的并发症率。结果显示抗生素组组织扩张器丢失率、非计划手术率和感染率均显著更低,但需随机对照试验进一步验证并确定最佳抗生素疗程。
要点
- 胸肌前乳房重建出院时预防性抗生素与更低的组织扩张器丢失、非计划手术和感染率相关。
- 抗生素组组织扩张器丢失率4.3% vs 17.0%(P=0.003)。
- 抗生素组感染率7.0% vs 24.5%(P<0.001),非计划手术率10.4% vs 24.5%(P=0.007)。
核心结论
- 胸肌前乳房重建术后预防性抗生素与显著更低的术后并发症率相关。
- 需进一步随机对照研究探索抗生素治疗对结局的影响并确定最佳疗程。
研究设计与样本
- 单术者回顾性研究,纳入2015至2018年乳房切除后立即行胸肌前组织扩张器置入的患者。
- 抗生素组69例患者115侧乳房,未用抗生素组63例患者106侧乳房。
主要发现
- 抗生素组组织扩张器丢失率4.3% vs 17.0%(P=0.003)。
- 抗生素组非计划手术率10.4% vs 24.5%(P=0.007)。
- 抗生素组感染率7.0% vs 24.5%(P<0.001)。
临床怎么用
- 胸肌前乳房重建术后可考虑预防性使用抗生素以降低组织扩张器丢失、非计划手术和感染风险。
- 最佳抗生素疗程尚未确定,需结合个体情况并等待随机对照试验证据。
局限性
- 回顾性单术者研究,可能存在选择偏倚和混杂因素。
- 样本量有限,需随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immediate tissue expander placement remains a preferred method for breast reconstruction after mastectomy. The use of prophylactic postoperative antibiotic administration is thought to reduce rates of surgical site infection and reconstructive failure, but has not been studied in patients undergoing reconstruction in the prepectoral plane. METHODS: We retrospectively identified all patients undergoing immediate prepectoral tissue expander placement after mastectomy by a single plastic surgeon from 2015 to 2018. We identified 2 cohorts of patients: one group that received prophylactic antibiotics at the time of discharge and one group that did not. We collected treatment and outcomes data to compare rates of postoperative complications between cohorts. RESULTS: We identified 69 patients with 115 breasts who received discharge antibiotics and 63 patients with 106 breasts who did not. The antibiotic cohort had significantly lower rates of tissue expander loss (4.3% vs 17.0%, P = 0.003), unplanned operation (10.4% vs 24.5%, P = 0.007), and infection (7.0% vs 24.5, P < 0.001). CONCLUSIONS: The use of prophylactic postoperative antibiotics in prepectoral breast reconstruction is associated with significantly lower rates of postoperative complications. Further randomized controlled studies are warranted to explore the effect of antibiotic therapy on outcomes and to determine what the optimal duration of antibiotic therapy may be.
引用
- Holland M, Lentz R, Sbitany H, et al. Utility of Postoperative Prophylactic Antibiotics in Prepectoral Breast Reconstruction: A Single-Surgeon Experience. Ann Plast Surg. 2021. PMID: 32472796. doi:10.1097/SAP.0000000000002407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。